Generics Industry Gets FTC OK For Shortage Prevention Plan
A generic-drug industry proposal to share sensitive information to help avert pending medication shortages will likely not violate antitrust rules, the Federal Trade Commission said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article